Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aktis Oncology
Biotech
Big Pharma backers return for Aktis' $175M series B
Eli Lilly was one of a number of Aktis’ returning backers that also included Bristol Myers Squibb and Merck & Co.’s MRL Ventures Fund.
James Waldron
Sep 30, 2024 8:00am
Lilly pays Aktis $60M to further dial into radiopharma signal
May 21, 2024 8:50am
Aktis Oncology makes waves with $161M series A total
Aug 25, 2022 6:30am
Bhargava leaves Gilead to take up post at biotech investor MPM
Apr 14, 2021 8:10am
Aktis Oncology bags $72M in Novartis, BMS-backed series A
Mar 18, 2021 9:05am
